GoodRx Holdings (GDRX) Tax Provisions (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Tax Provisions data on file, last reported at $4.5 million in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions fell 20.41% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $25.0 million (up 28.73% YoY), and the FY2025 full-year result was $26.1 million, up 73.19% from the prior year.
• Tax Provisions slipped to $4.5 million in Q1 2026, from $8.8 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $19.5 million in Q3 2022 to a low of -$46.7 million in Q2 2023.
• A 5-year average of $501882.4 and a median of $4.5 million in 2026 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions tumbled 434.29% in 2023 and soared 331.34% in 2025, its largest moves.
• Tracing GDRX's Tax Provisions over 5 years: stood at -$2.8 million in 2022, then surged by 144.5% to $1.2 million in 2023, then soared by 278.36% to $4.7 million in 2024, then surged by 87.79% to $8.8 million in 2025, then sank by 49.02% to $4.5 million in 2026.
• Business Quant data shows GDRX's Tax Provisions at $4.5 million in Q1 2026, $8.8 million in Q4 2025, and $5.0 million in Q3 2025.